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1. Low Alcohol, Fruit Flavored Coolers Offer Tropical Escape From Summer Heat

BevNet – The Beverage Network
May 19, 2003
Seagram's Coolers has just introduced 2 new flavors Orange Pineapple Bahama Mama and Raspberry Daiquiri - just in time for summer.


Stamford, CT, May 14, 2003 -- With the hazy days of summer approaching and a growing interest in fruit flavored beverages, Seagram's Coolers has created two new flavors to quench thirsts and keep cool in the hot summer sun.

Orange Pineapple Bahama Mama and Raspberry Daiquiri are the newest flavors from Seagram's Coolers, a leader in the cooler category for over 20 years. Low in alcohol, coolers make the perfect beverage choice for backyard barbecues or a day at the beach. Offered in a variety of delicious blends of raspberries, strawberries, blueberries, blackberries, peaches and lemon and lime, Seagram's Coolers will tantalize taste buds and add a taste of the tropics to summertime activities. 

The new styles are being launched with newly redesigned packaging developed by U.S. Beverage that features colorful, tropical imagery to match the brand's new tagline, "Escape to a Cooler Place."

"Low alcohol refreshers are becoming increasingly popular, and the variety of styles indulge many taste preferences," said Joseph Fisch, President and CEO of United States Beverage. "Cooler's particularly appeal to female consumers looking for a low alcohol alternative to beer or wine, especially in the summer months."
 




Pernod Ricard USA is a major player in the spirits and wine industry. With a broad portfolio of premium brands and a presence in all major categories, Pernod Ricard USA has organized management and brand structures to handle a threefold increase in volume to over six million cases annually.

About United States Beverage







2. Four Roses Plans U.S. Marketing, Distribution

By Holly Cecil - The Kentucky Standard
May 19, 2003
Four Roses Brand Distillery pre-dates Prohibition in Kentucky, but it hasn't been nationally marketed or distributed since about 1960.
As of this year, that will no longer be the case.
Recently, the product, wholly owned by Japanese company Kirin Brewing Company, Ltd. since 2002, selected Louisville marketing firm Vimark to launch it into the United States bourbon industry once again.
Master Distiller Jim Rutledge has been waiting for this for decades.
Since 1996, Rutledge has managed to keep the bourbon listed in Kentucky, but Seagram, the brand's former owner, always placed its emphasis -- intellectual and financial -- on foreign markets for bourbon.
Four Roses was a top seller in markets such as France and Spain, not to mention Japan. Domestic marketing was reserved for other Seagram products.
"We were a little dot with Seagram," Rutledge said. "We're the big ball with Kirin."
Kirin formerly had the distribution rights to Four Roses in Japan. It was the number-one selling bourbon there.
The company had a lot to lose if Four Roses was sold to another company that might have chosen to close the distillery, Rutledge said.
So, when Seagram was bought by the English company Diageo and the French company Pernot Ricard, and Four Roses went as a third party sale, Kirin bought it.
First focusing on re-establishing global markets that had declined slightly due to the sale, the Japanese company had other plans for the brand name as well.
"From the very start, they wanted to come back into the U.S.," Rutledge said.
All-inclusive Vimark landed the account because its proposal and strategies mirrored those already in place in foreign markets.
"It's a continuation of what's already being done," Rutledge said.
The up-and-coming midsize group was one of several targeted by Kirin and Four Roses representatives in the search for marketing expertise.
"In a large firm, you could potentially be just another client," Rutledge said. "With this group, our success is their success and vice versa. It means as much to them as it does to us. It's a nice marriage."
The company is also located a "stone's throw" away from Southern Wine and Spirits, the largest distributor in the U.S., with whom Four Roses is already listed in Kentucky.
Rutledge admits, carving its own niche in the U.S. market will be no easy task for Four Roses.
In fact, getting the company to this point has been an exciting and challenging journey on its own.
Not only was the sale of the distillery and brand a traumatic time, with employees wondering how the company's fate -- and their own fates -- would pan out, but, since the brand was bought by Kirin, Four Roses staff members have taken on a lot more responsibility within the company.
Seagram was a huge company with marketing, human resources, benefits, risk management, etc., Rutledge said. All that has fallen back to the staff at Four Roses.
"I've learned more in the past year and a half than I did the 36 years before that," Rutledge said.
With about 42 employees in the Lawrenceburg distillery and 16 at the warehouse on KY 245, the company produces 280-285 barrels a day.
It's likely the single-barrel product will show itself in the market first. It's a smaller production run, Rutledge said.
Though there is no firm marketing strategy in place as yet -- it is still in the research and planning phase -- one decision has already been made.
Kentucky will be the test market for the bourbon, hopefully in late summer, early fall of this year, Rutledge said.
"Why any other state than the home of Kentucky Bourbon?" he said. "I thought it was perfect."






4. Owner of Miller Beer to Buy Most of Big Italian Brewer

By Heather Timmons – The New York Times
May 15, 2003

LONDON, May 14 — SABMiller, one of the world's largest brewers, said today that it was buying a majority stake in Peroni of Italy for as much as $280 million. 
The deal is the first major transaction by SABMiller since it bought Miller Brewing from Philip Morris (​http:​/​​/​www.nytimes.com​/​redirect​/​marketwatch​/​redirect.ctx?MW=http:​/​​/​custom.marketwatch.com​/​custom​/​nyt-com​/​html-companyprofile.asp&symb=MO​) last year for $2.6 billion.
SABMiller, formerly South African Breweries (​http:​/​​/​www.nytimes.com​/​redirect​/​marketwatch​/​redirect.ctx?MW=http:​/​​/​custom.marketwatch.com​/​custom​/​nyt-com​/​html-companyprofile.asp&symb=SBWUY​), has had rapid growth in Asia and other developing countries.
Italy is the only Western European country besides Spain where beer consumption is increasing, the chief executive of SABMiller, Graham Mackay, said in a conference call today. He expects sales of Peroni, which already controls 25.2 percent of the Italian market, to increase. Additionally, SABMiller predicts it can cut $10.2 million from Peroni's operating costs after three years.
Mr. Mackay also said that Italy's strong import market offers potential for sales of other SABMiller brands. SABMiller owns Miller High Life, Pilsner Urquell and Olde English 800, among other beers. 
The company will buy 51 to 60 percent of Peroni in a deal that is expected to close in the next three weeks. SABMiller will increase its ownership to 80 to 100 percent over the next three to five years. The $280 million figure assumes SABMiller will buy 60 percent of the company from shareholders, and values all of Peroni at $465 million.
Some analysts questioned whether SABMiller paid too much to expand in Italy. The price is 12.6 times Peroni's operating cash flow, said Stuart Price, an analyst with WestLB, an "`even higher multiple than we expected."
Shares of SABMiller fell 3.6 percent, to 443 pence in London trading.
Peroni has been family-owned for five generations. SABMiller will appoint a new board, chairman and managing director for the company after the deal closes.
An increase in Italian beer sales has come at the expense of wine sales. In 1975 the average Italian drank 104 liters of wine, according to Assobirra, the Italian beer association. By 1999, that number fell to 51.5 liters. Beer consumption in the country increased to 27.1 liters from 12.8 liters a person in the same period.
The deal makes SABMiller a strong rival of Anheuser Busch in Italy. Sales of Budweiser from Anheuser-Busch grew 3 percent there in 2002.

5. Health Benefits of Beer Could Surpass Wine, Studies Indicate

The (Appleton, Wis.) Post Crescent
May. 21, 2003 08:45 AM


Blame it on the French.

Current research into the health benefits of moderate alcohol consumption is a result of the "French paradox."

Although the French have a high-fat diet, smoke more than Americans and exercise even less, the rate of heart disease is approximately one-third the U.S. heart attack rate.

The French tendency to drink red wine with meals has been cited as the possible reason for the medical anomaly.

The grapes in red wine - and in grape juice - have high concentrations of flavonoids, which have been proven to reduce artery-narrowing blood platelet activity and introduce powerful free radical-fighting anti-oxidant protection into the bloodstream.

But a flurry of independent research since those initial reports on red wine's health benefits surfaced a dozen years ago finds that alcohol in general provides a number of health benefits when consumed in moderation, and that beer might be the healthiest beverage of them all. As brewer/patriot Thomas Jefferson said a couple hundred years ago, "Beer, if drank in moderation, softens the temper, cheers the spirit, and promotes health."

"The wine people have made a very impressive marketing ploy. I think it's a snow job," says Dr. Norman Kaplan, a hypertension specialist at the University of Texas Southwestern Medical Center in Dallas. "Be that as it may, most people are convinced if you are going to get any benefit, it's going to be from red wine."

Kaplan became something of a national media star last summer when he took the lead in presenting a report on a Texas Southwestern study on the health benefits of moderate beer consumption.

"It got a lot of publicity at the time," he says. "Since that time, there have been other studies that have documented the relative benefit of beer over other types of alcohol."

Kaplan says he has been on record for as long as 20 years touting the benefits of moderate alcohol consumption, and mounting evidence through independent research being conducted around the world is showing that moderate beer consumption - one or two beers a day - might be one of the best things you can do for your body and mind.

"It's sort of like taking an aspirin to prevent strokes and heart disease," he says. "There is a large body of evidence that small quantities of alcohol provide protection against coronary heart attack, but also there is evidence about stroke, heart failure and osteoporosis, and, most recently and most interestingly, dementia."

"Most everything says that two alcoholic drinks a day is sort of the therapeutic level, and anything above that ... not only doesn't it do any good as far as preventing disease, but it is detrimental because then it starts to cause problems with car accidents and other problems to your health," says Dr. Lowell Peterson, a cardiologist at the Appleton (Wis.) Heart Institute.

Peterson says he has been following the research on alcohol therapy for more than 10 years.

"Mostly since the French paradox thing came out," he says.

Peterson says the darker the drink, the better.

"Red wine is better than white wine, and dark beer is better than light beer," he says. "There are more flavonoids present."

Researchers at Oregon State University have published 10 papers on the biological activities of flavonoids unique to hops, the leafy buds used for bittering and spicing beers.

Dr. Cristobal Miranda, who has co-authored several of those papers, says they have used hops flavonoids to inhibit the growth of cancer cells in test tubes.

Miranda's department will be presenting another paper at a symposium this month that looks at the highly potent anti-oxidant properties of xanthohumol, a major hop flavonoid that has potent estrogenic properties.

"So far it is the most estrogenic phytochemical discovered, much more potent than the major component in soy," Miranda says. "It is unique, different from those we already know about."

Those studies could one day result in a natural hormone replacement therapy drug for post-menopausal women, without the side effects of currently available HRT drugs.

A European drug company is supposedly already testing hops on humans for that very purpose and will soon market a hops-powered HRT drug.

"In Germany, a beer has been out on the market known as High Xanthohumol Beer that is 10 times higher in xanthohumol," Cristobal says.

The New England Journal of Medicine has published research papers in recent years attributing health benefits to moderate alcohol consumption.

On Jan. 9, the journal carried a report on a 12-year study of 38,077 health professionals that concluded those in the group who drank moderately (at least four days a week) had about 20 percent less risk of heart attack.

Researchers found the risk of heart attack among healthy, middle-aged men who did not drink was 420 in 100,000, while the risk among moderate drinkers was 145 in 100,000.

The study concluded that adults should discuss alcohol consumption with their doctors.

An accompanying editorial by Dr. Ira Goldberg of the Division of Preventive Medicine and Nutrition at Columbia College reported that the study also found those who abstain from alcohol get the least physical activity, have a greater occurrence of diabetes and higher concentrations of trans- and saturated fats and have the lowest levels of vitamin E in their systems.

Goldberg suggested a study of alcohol therapy on patients already suffering heart disease in order to "advise patients with cardiovascular disease on the use of alcoholic beverages as medical therapy."

But, Kaplan says doctors generally are not talking to patients about alcohol because of all the negative societal connotations.

"I don't think many physicians are telling their patients, 'If you don't drink, you should start,' although, that, I think, is at least a question that should be raised because the benefits are there and I think a lot of people are not aware of those benefits," he says. "Many people are frightened because alcohol is a major drug of abuse and they don't want to expose themselves to that. I understand that."

"I think that it gets to be a personal decision with the doctors," Peterson says. "There are certain doctors who would never, ever recommend this. I think some people are so anti-alcohol that they would never recommend it."

But, he adds, if alcohol therapy helps to prolong life, then it should be considered.

"When you're dealing with a young person with heart disease, you try to pull out all the stops and give them every advantage," he says. "In my estimation, it should include not only the statins (drugs to treat high cholesterol), but also anti-oxidant vitamins, folic acid and red wine."

While Kaplan is a proponent of alcohol therapy, he advises that people should also eat right and exercise.

"I think if we tell people a little bit of alcohol is healthy, we ought to be sure to tell them to walk to the liquor store," he says. 






